Hint mode is switched on Switch off
For swift navigation between sections

MMCB Bonds, BO-P01-01 (FIGI BBG00N6MZ8T7, 4B02-01-85932-H-001P, ММЦБ П01-1, RU000A1001T8)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard

PDF download

Choose all Reset all
Download Cancel

Domestic bonds

Issue | Issuer
Issuer
  • ACRA
      | ***
    ***
Status
Outstanding
Amount
30,000,000 RUB
Placement
***
Redemption (put/call option)
*** (-)
ACI
Country of risk
Russia
Current coupon
***%
Price
Yield / Duration
Calculate in two clicks! yield, duration and other parameters
Calculate in two clicks! yield, duration and other parameters
Calculator What is a calculator?
  • Amount
    30,000,000 RUB
  • Placement amount
    30,000,000 RUB
  • Outstanding amount
    30,000,000 RUB
  • USD equivalent
    403,792.42 USD
  • Face value
    1,000 RUB
  • ISIN
    RU000A1001T8
  • CFI
    DBVUFB
  • FIGI
    BBG00N6MZ8T7
  • Ticker
    MMCOKB V11.75 01/12/29 BOP1

Try in 7-days Trial access

Free for company representative

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
  • Evaluate advanced analytical tools
Sign up

Why Cbonds?

  • 24 Years of Market Leadership
  • Trusted by clients across 90 countries for decades of reliable service
  • Used by Financial Professionals & Fintech central banks, asset managers, fintech innovators
  • Convenient platform for private investors for informed investment decisions

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Files

Release and placement notices (2 pcs.)

Prospectus

Show all Hide
Authorization required
It is only possible to download bond prospectuses for paid Premium subscription access

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
No more than two exchanges can be selected for comparison at the same time
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription

Issue information

Profile
International Medical Center for Processing and Cryopreservation of Biomaterials PJSC was established by Human Stem Cells Institute PJSC in October 2014 to carry out activities on personal banking of hematopoietic stem cells of umbilical cord blood ...
International Medical Center for Processing and Cryopreservation of Biomaterials PJSC was established by Human Stem Cells Institute PJSC in October 2014 to carry out activities on personal banking of hematopoietic stem cells of umbilical cord blood and other valuable biomaterials. The spin-off into a subsidiary was made in order to more efficiently manage the business of Gemabank, created by HSCI in 2003, as well as to use state incentives for taxing the profits of medical companies. Gemabank is a licensed bank for personal storage of umbilical cord blood cells and umbilical cord. It complies with the requirements of international GMP standards. The transfer of Gemabank's activities to the "IMCB" PJSC began in 2015 after the appropriate licensing.
Show more Hide
Research report by Cbonds-PRAAMS Save
Authorization required
Report download is available only paid Premium subscription access
  • Issuer
    Go to the issuer page
    MMCB
  • Full borrower / issuer name
    MMCB
  • Sector
    Corporate
  • Industry
    Pharmaceutical Preparation and Biotechnology
  • Stocks
    MMCB, ordinary share
Volume
  • Announced amount
    30,000,000 RUB
  • Placement amount
    30,000,000 RUB
  • Outstanding amount
    30,000,000 RUB
  • Outstanding face value amount
    30,000,000 RUB
  • USD equivalent
    403,792 USD
Face value
  • Face value
    1,000 RUB
  • Outstanding face value
    *** RUB
Listing
  • Listing

Get access to the largest bond database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest bond database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Cash flow parameters

  • Variable rate type
    Issuer decision
  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Business Day Convention
    Following Business Day
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Export to Excel

Early redemption terms

***

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Placement format
    Book building
  • Order book
    *** (***) - *** (***)
  • Placement
    *** - ***
  • Initial issue price (yield)
    (***%)
  • Number of trades on stock exchange
    7
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Use of proceeds
    Other
Participants
  • Bookrunner
    ***
  • Underwriter
    ***
  • Depository
    ***
  • Bondholders Representative
    ***

Conversion and exchange

  • Conversion terms
    ***

Latest issues

Show all

Similar issues

News

30/07/2021 MMCB announces about increased RAS net profit for 6 months of 2021, up 16.77% YoY. Total revenue’s increase is 14.02%
03/05/2021 RAS. MMCB. March 31, 2021: long-term liabilities’ increase is 9.96 % YoY
02/04/2021 MMCB announces decreased RAS net profit for 2020, down 2.95 % YoY
14/04/2020 MMCB’s 4 Q 2019 Y IFRS results were published
30/03/2020 Gazprom’s, VimpelCom’s, Transneft’s, Rossium’s, Mediaholding’s, VEB-Leasing’s, Western High-Speed Diameter’s, Human Stem Cell Institute’s 4 Q 2019 Y RAS results were published
All organization news

IFRS/US GAAP reports

2022
II q NTL
IV q NTL
2021
II q NTL
IV q NTL
2020
IV q NTL
2019
IV q NTL
2018
IV q NTL
Show all Hide
Authorization required
You need to request access

Related entities on 01/08/2023

Have shares in the company

In which the company has interests

Identifiers

  • State registration number
    4B02-01-85932-H-001P
  • Registration
    ***
  • State registration number of program
    4-85932-H-001P-02E
  • Date of program registration
    ***
  • ISIN
    RU000A1001T8
  • Cbonds ID
    493857
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DBVUFB
  • Issue short name on trading floor
    ММЦБ П01-1
  • FIGI
    BBG00N6MZ8T7
  • Ticker
    MMCOKB V11.75 01/12/29 BOP1
  • Type of security by CBR
    ***
Show more Hide

Ratings

Bond classification

  • Rank: Undefined
  • Exchange bonds
  • Documentary bonds
  • Coupon bonds
  • Bearer
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Non-complex financial instruments (MiFID)
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

Issuer's quarterly reports/RAS Reports

2026
I q NTL
2025
I q NTL
II q NTL
III q NTL
IV q NTL
2024
I q NTL
II q NTL
III q NTL
IV q NTL
2023
I q NTL
II q NTL
III q NTL
IV q NTL
2022
I q NTL
II q NTL
III q NTL
IV q NTL
2021
I q NTL
II q NTL
III q NTL
IV q NTL
2020
I q NTL
II q NTL
III q NTL
IV q NTL
2019
I q NTL
II q NTL
III q NTL
IV q NTL
2018
IV q NTL
2017
IV q NTL
2016
IV q NTL
Show all Hide
Authorization required
You need to request access

Annual reports

2025
IV q NTL
2024
IV q NTL
2023
IV q NTL
2022
IV q NTL
Show all Hide
Authorization required
You need to request access
Registration is required to get access.